Farmako logo
HomeMedicine DeliveryABDM
Decorative illustration
HomeMedicine DeliveryABDM
footer illustration
HomePrivacy PolicyTerms & Conditions
Download the App
play-storeapp-store
Copyright Farmako Healthcare Private Limited © 2025 All rights reserved
facebooktwitterlinkedininstagram
medicine
medicine
medicine

Switglim MV 1mg/500mg/0.3mg Tablet

strip of 10.0 tablets
Prescription Required
30 minute delivery
strip of 10.0 tablets
₹ 147.30
Get it on upto a 20% discount on Farmako
Delivering to
Out of Stock
Ask Life AI anything about this medicine
Tell me about medicines!

Manufacturer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Key InformationDirections for UseSafety InformationHow it worksQuick Tips

Manufacturer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Key Information

Short Description

Switglim MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.

Dosage Form

Tablet

Introduction

Switglim MV 1mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.

Directions for Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Switglim MV 1mg/500mg/0.3mg Tablet is to be taken empty stomach.

Safety Information

Side Effects

No common side effects listed.

Alcohol Warning

Alcohol Warning

It is unsafe to consume alcohol with Switglim MV 1mg/500mg/0.3mg Tablet.

Breastfeeding Warning

Breastfeeding Warning

Switglim MV 1mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Pregnancy Warning

Pregnancy Warning

Switglim MV 1mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

How it works

Switglim MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:

Quick Tips

Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).

Short Description

Switglim MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.

Dosage Form

Tablet

Introduction

Switglim MV 1mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Switglim MV 1mg/500mg/0.3mg Tablet is to be taken empty stomach.

Side Effects

No common side effects listed.
Alcohol Warning

Alcohol Warning

It is unsafe to consume alcohol with Switglim MV 1mg/500mg/0.3mg Tablet.
Breastfeeding Warning

Breastfeeding Warning

Switglim MV 1mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning

Pregnancy Warning

Switglim MV 1mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Switglim MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).

Related Medicines

medicine

Vogs GM 1mg/500mg/0.3mg Tablet

1 Strip of 10 Tablets
20% off1 Strip of 10 Tablets
₹ 89.00
20% off
medicine

Glimitos MV Tablet

strip of 15.0 tablets
20% offstrip of 15.0 tablets
₹ 203.00
20% off
medicine

Glycebose GM 1.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 130.00
20% off
medicine

Jubiglim MV 1mg/500mg/0.3mg Tablet

strip of 15.0 tablets
20% offstrip of 15.0 tablets
₹ 198.20
20% off
medicine

Voglow 0.3 GM1 Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 122.00
20% off
medicine

Glimee MV 1mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 123.00
20% off
medicine

Hmet Trio 1mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 131.00
20% off
medicine

Voglimust MF 1mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 92.40
20% off
medicine

Vobrryl Trio 1mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 100.00
20% off
medicine

Glimitos MV 1mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 160.00
20% off

Frequently asked questions

What is Switglim MV 1mg/500mg/0.3mg Tablet?

Switglim MV 1mg/500mg/0.3mg Tablet contains Glimepiride, Metformin, and Voglibose. This medication is prescribed for the treatment of type 2 diabetes mellitus (DM). It helps manage blood glucose levels in adults when taken with a balanced diet and regular physical activity. Glimepiride increases insulin release from the pancreas. Metformin lowers glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that reduces postprandial (after meals) glucose levels.

What are possible side effects of Switglim MV 1mg/500mg/0.3mg Tablet?

Common side effects associated with Switglim MV 1mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.

Are there specific conditions in which Switglim MV 1mg/500mg/0.3mg Tablet should not be taken?

Switglim MV 1mg/500mg/0.3mg Tablet is contraindicated for patients with known allergy to any of the ingredients or excipients, as well as those with moderate to severe kidney disease and inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.

Is it safe to take alcohol while taking Switglim MV 1mg/500mg/0.3mg Tablet?

No, consuming alcohol with Switglim MV 1mg/500mg/0.3mg Tablet is not recommended as it can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.

Can Switglim MV 1mg/500mg/0.3mg Tablet cause hypoglycemia?

Yes, Switglim MV 1mg/500mg/0.3mg Tablet can lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely to occur if you miss meals, consume alcohol, engage in excessive physical activity, or take other diabetes medications concurrently.

What are the instructions for storage and disposal of Switglim MV 1mg/500mg/0.3mg Tablet?

Store Switglim MV 1mg/500mg/0.3mg Tablet in its original packaging, tightly sealed. Follow the storage instructions provided on the package label. Dispose of unused medication safely and ensure that it is not accessed by children, pets, or other individuals.

Switglim MV 1mg/500mg/0.3mg Tablet contains Glimepiride, Metformin, and Voglibose. This medication is prescribed for the treatment of type 2 diabetes mellitus (DM). It helps manage blood glucose levels in adults when taken with a balanced diet and regular physical activity. Glimepiride increases insulin release from the pancreas. Metformin lowers glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that reduces postprandial (after meals) glucose levels.
Common side effects associated with Switglim MV 1mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Switglim MV 1mg/500mg/0.3mg Tablet is contraindicated for patients with known allergy to any of the ingredients or excipients, as well as those with moderate to severe kidney disease and inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, consuming alcohol with Switglim MV 1mg/500mg/0.3mg Tablet is not recommended as it can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Switglim MV 1mg/500mg/0.3mg Tablet can lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely to occur if you miss meals, consume alcohol, engage in excessive physical activity, or take other diabetes medications concurrently.
Store Switglim MV 1mg/500mg/0.3mg Tablet in its original packaging, tightly sealed. Follow the storage instructions provided on the package label. Dispose of unused medication safely and ensure that it is not accessed by children, pets, or other individuals.
India' first 30 minutes
medicine delivery service
percentage
Get atleast 20% discount on all medicines
shield
We always ensure genuine medicines and qualified doctors
deliver
Completed over 2 lakhs super-fast deliveries